Quantitative fecal lactoferrin in toxin-positive and toxin-negative Clostridium difficile specimens

Journal of Clinical Microbiology

Volumn 51, Issue 1, 2013, Pages 311-313

  LaSala, P Rocco ^a   Ekhmimi, Tariq ^a,b   Hill, A Kate ^a   Farooqi, Imran ^a   Perrotta, Peter L ^a  

^a not available   (United States)

^b KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; GLUTAMATE DEHYDROGENASE; LACTOFERRIN;

ARTICLE; BACTERIUM CULTURE; CLOSTRIDIUM DIFFICILE; CYTOTOXICITY; ELECTRONIC MEDICAL RECORD; ENZYME IMMUNOASSAY; FECES ANALYSIS; GENE DOSAGE; HUMAN; LEUKOCYTE COUNT; MOLECULAR DYNAMICS; NONHUMAN; NUCLEIC ACID ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SERODIAGNOSIS; TOXICOGENIC CLOSTRIDIUM DIFFICILE;

CLOSTRIDIUM DIFFICILE;

EID: 84871685474     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02735-12     Document Type: Article

References (23)

1. Shetty N, Wren MW, Coen PG. 2011. The role of glutamate dehydrogenase for the detection of Clostridium difficile in faecal samples: a meta-analysis. J. Hosp. Infect. 77:1-6.
2. Tenover FC, Baron EJ, Peterson LR, Persing DH. 2011. Laboratory diagnosis of Clostridium difficile infection can molecular amplification methods move us out of uncertainty? J. Mol. Diagn. 13:573-582.
3. Rene P, Frenette CP, Schiller I, Dendukuri N, Brassard P, Fenn S, Loo VG. 2012. Comparison of eight commercial enzyme immunoassays for the detection of Clostridium difficile from stool samples and effect of strain type. Diagn. Microbiol. Infect. Dis. 73:94-96.
4. Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, Pepin J, Wilcox MH. 2010. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect. Control Hosp. Epidemiol. 31:431-455.
5. Wilcox MH. 2011. Laboratory diagnosis of Clostridium difficile infection: in a state of transition or confusion or both? J. Hosp. Infect. 79:1-3.
6. Wilcox MH, Planche T, Fang FC, Gilligan P. 2010. What is the current role of algorithmic approaches for diagnosis of Clostridium difficile infection? J. Clin. Microbiol. 48:4347-4353.
7. Orendi JM, Monnery DJ, Manzoor S, Hawkey PM. 2012. A two-stage algorithm for Clostridium difficile including PCR: can we replace the toxin EIA? J. Hosp. Infect. 80:82-84.
8. Carter GP, Rood JI, Lyras D. 2012. The role of toxin A and toxin B in the virulence of Clostridium difficile. Trends Microbiol. 20:21-29.
9. Ryder AB, Huang Y, Li H, Zheng M, Wang X, Stratton CW, Xu X, Tang YW. 2010. Assessment of Clostridium difficile infections by quantitative detection of tcdB toxin by use of a real-time cell analysis system. J. Clin. Microbiol. 48:4129-4134.
10. Awad-El-Kariem F, Brown N, Malone C, Gough H, Yates C, O'Connor H. 2012. Clostridium difficile detection: identification of colonization, subclinical and overt disease. J. Hosp. Infect. 82:138-139.
11. Polage CR, Chin DL, Leslie JL, Tang J, Cohen SH, Solnick JV. 22 September 2012. Outcomes in patients tested for Clostridium difficile toxins. Diagn. Microbiol. Infect. Dis. [Epub ahead of print.10.1016/j.diagmicrobio.2012.08.019.
12. Department of Health. 2012. Update guidance on the diagnosis and reporting of Clostridium difficile. Department of Health, National Health Service, London, United Kingdom.
13. Guerrero DM, Chou C, Jury LA, Nerandzic MM, Cadnum JC, Donskey CJ. 2011. Clinical and infection control implications of Clostridium difficile infection with negative enzyme immunoassay for toxin. Clin. Infect. Dis. 53:287-290.
14. Curry SR, Schlackman JL, Hamilton TM, Henderson TK, Brown NT, Marsh JW, Shutt KA, Brooks MM, Pasculle AW, Muto CA, Harrison LH. 2011. Perirectal swab surveillance for Clostridium difficile by use of selective broth preamplification and real-time PCR detection of tcdB. J. Clin. Microbiol. 49:3788-3793.
15. Loo VG, Bourgault AM, Poirier L, Lamothe F, Michaud S, Turgeon N, Toye B, Beaudoin A, Frost EH, Gilca R, Brassard P, Dendukuri N, Beliveau C, Oughton M, Brukner I, Dascal A. 2011. Host and pathogen factors for Clostridium difficile infection and colonization. N. Engl. J. Med. 365:1693-1703.
16. Riggs MM, Sethi AK, Zabarsky TF, Eckstein EC, Jump RL, Donskey CJ. 2007. Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. Clin. Infect. Dis. 45:992-998. (Pubitemid 47580347)
17. Dubberke ER, Han Z, Bobo L, Hink T, Lawrence B, Copper S, Hoppe-Bauer J, Burnham CA, Dunne WM, Jr. 2011. Impact of clinical symptoms on interpretation of diagnostic assays for Clostridium difficile infections. J. Clin. Microbiol. 49:2887-2893.
18. Peterson LR, Manson RU, Paule SM, Hacek DM, Robicsek A, Thomson RB, Jr, Kaul KL. 2007. Detection of toxigenic Clostridium difficile in stool samples by real-time polymerase chain reaction for the diagnosis of C. difficile-associated diarrhea. Clin. Infect. Dis. 45:1152-1160. (Pubitemid 47580313)
19. Manabe YC, Vinetz JM, Moore RD, Merz C, Charache P, Bartlett JG. 1995. Clostridium difficile colitis: an efficient clinical approach to diagnosis. Ann. Intern. Med. 123:835-840.
20. Schleupner MA, Garner DC, Sosnowski KM, Schleupner CJ, Barrett LJ, Silva E, Hirsch D, Guerrant RL. 1995. Concurrence of Clostridium difficile toxin A enzyme-linked immunosorbent assay, fecal lactoferrin assay, and clinical criteria with C. difficile cytotoxin titer in two patient cohorts. J. Clin. Microbiol. 33:1755-1759.
21. Yong WH, Mattia AR, Ferraro MJ. 1994. Comparison of fecal lactoferrin latex agglutination assay and methylene blue microscopy for detection of fecal leukocytes in Clostridium difficile-associated disease. J. Clin. Microbiol. 32:1360-1361. (Pubitemid 24132577)
22. Steiner TS, Flores CA, Pizarro TT, Guerrant RL. 1997. Fecal lactoferrin, interleukin-1beta, and interleukin-8 are elevated in patients with severe Clostridium difficile colitis. Clin. Diagn. Lab. Immunol. 4:719-722. (Pubitemid 27501413)
23. Wren MW, Sivapalan M, Kinson R, Shetty NR. 2009. Laboratory diagnosis of Clostridium difficile infection. An evaluation of tests for faecal toxin, glutamate dehydrogenase, lactoferrin and toxigenic culture in the diagnostic laboratory. Br. J. Biomed. Sci. 66:1-5.